CureVac (CVAC)
(Delayed Data from NSDQ)
$5.41 USD
-0.04 (-0.73%)
Updated Oct 6, 2025 04:00 PM ET
After-Market: $5.42 +0.01 (0.18%) 5:54 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, CureVac N.V. has a market cap of $1.22B, which represents its share price of $5.45 multiplied by its outstanding shares number of 224.34M. As a small-cap company, CVAC's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CVAC 5.41 -0.04(-0.73%)
Will CVAC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CVAC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CVAC
Oncobiologics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates
Kamada (KMDA) Q2 Earnings Top Estimates
CVAC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Coya Therapeutics, Inc. (COYA) Reports Q2 Loss, Lags Revenue Estimates
Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Lags Revenue Estimates
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates
Other News for CVAC
Is CVAC set to rally? Crossed Above 50 Day Moving Average shows up after gaining 1.11%
50 Day Moving Average Resistance appears for CVAC after 0.37% move
CVAC forms Directional Movement Crossover Bullish on October 1
Crossed Above 20 Day Moving Average appears for CVAC after 0.75% move
CureVac: The Hidden Value Of The mRNA Wallet